• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.人类白细胞抗原I类分子限制的T细胞应答可能有助于控制人类免疫缺陷病毒感染,但这种应答对于长期病毒控制并非总是必要的。
J Virol. 2008 Jun;82(11):5398-407. doi: 10.1128/JVI.02176-07. Epub 2008 Mar 19.
2
CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.CD8 + T细胞广度和体外病毒抑制能力可区分有无保护性HLA I类等位基因的病毒血症控制者。
J Virol. 2016 Jul 11;90(15):6818-6831. doi: 10.1128/JVI.00276-16. Print 2016 Aug 1.
3
Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.免疫优势 HIV 特异性 CD8+ T 细胞应答在血液和胃肠道黏膜中很常见,而 gag 特异性应答在 HIV 控制者的直肠黏膜中占主导地位。
J Virol. 2010 Oct;84(19):10354-65. doi: 10.1128/JVI.00803-10. Epub 2010 Jul 28.
4
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.具有 HLA-DRB1*13 和 HLA-DQB1*06 等位基因的 HIV 控制器具有强大的、多功能的粘膜 CD4+ T 细胞反应。
J Virol. 2010 Nov;84(21):11020-9. doi: 10.1128/JVI.00980-10. Epub 2010 Aug 18.
5
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.精英控制者对HIV-1的黏膜免疫反应:免疫控制的一个潜在相关因素。
Blood. 2009 Apr 23;113(17):3978-89. doi: 10.1182/blood-2008-10-182709. Epub 2008 Dec 23.
6
Case report: mechanisms of HIV elite control in two African women.病例报告:两名非洲女性中 HIV 精英控制的机制。
BMC Infect Dis. 2018 Jan 25;18(1):54. doi: 10.1186/s12879-018-2961-8.
7
Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.HIV 病毒控制者和非控制者脑脊液中的免疫激活与 HIV 特异性 CD8(+) T 细胞
AIDS Res Hum Retroviruses. 2016 Aug;32(8):791-800. doi: 10.1089/AID.2015.0313. Epub 2016 May 2.
8
Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.队列研究中既往 HIV 控制者病毒迅速失控的机制。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01436-18. Print 2019 Feb 15.
9
Analysis of the CD8 T cell anti-HIV activity in heterologous cell co-cultures reveals the benefit of multiple HLA class I matches.分析异源细胞共培养物中的 CD8 T 细胞抗 HIV 活性,揭示了多个 HLA Ⅰ类匹配的益处。
Immunogenetics. 2018 Feb;70(2):99-113. doi: 10.1007/s00251-017-1021-7. Epub 2017 Jul 22.
10
Poor HIV control in HLA-B*27 and B*57/58 noncontrollers is associated with limited number of polyfunctional Gag p24-specific CD8+ T cells.HLA-B*27 和 B*57/58 非控制者中 HIV 控制不佳与 Gag p24 特异性 CD8+ T 细胞的多功能性数量有限有关。
AIDS. 2013 Jan 2;27(1):17-27. doi: 10.1097/QAD.0b013e32835ac0e1.

引用本文的文献

1
From network biology to immunity: potential longitudinal biomarkers for targeting the network topology of the HIV reservoir.从网络生物学到免疫:用于靶向HIV储存库网络拓扑结构的潜在纵向生物标志物。
J Transl Med. 2025 Aug 13;23(1):906. doi: 10.1186/s12967-025-06919-z.
2
Immune signatures and biomarkers of viral control in early-treated children with HIV: insights informing intervention.早期接受治疗的HIV感染儿童病毒控制的免疫特征和生物标志物:为干预提供信息的见解
Curr Opin HIV AIDS. 2025 May 1;20(3):265-270. doi: 10.1097/COH.0000000000000929. Epub 2025 Mar 24.
3
Acute HIV-1 Infection: Paradigm and Singularity.急性人类免疫缺陷病毒1型感染:范例与独特性
Viruses. 2025 Mar 3;17(3):366. doi: 10.3390/v17030366.
4
Human models that inform antiretroviral therapy-free remission with perinatally acquired HIV infection.为围产期获得性HIV感染的无抗逆转录病毒治疗缓解提供信息的人体模型。
Curr Opin HIV AIDS. 2025 May 1;20(3):249-256. doi: 10.1097/COH.0000000000000918. Epub 2025 Mar 19.
5
Persistent elite controllers as the key model to identify permanent HIV remission.持续精英控制者作为识别HIV永久缓解的关键模型。
Curr Opin HIV AIDS. 2025 Mar 1;20(2):165-171. doi: 10.1097/COH.0000000000000907. Epub 2025 Jan 17.
6
NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control.NKG2C 和 NKG2A 共表达定义了具有高度抗病毒功能的自然控制 HIV 的 NK 群体。
JCI Insight. 2024 Sep 17;9(20):e182660. doi: 10.1172/jci.insight.182660.
7
Exceptional, naturally occurring HIV-1 control: Insight into a functional cure.异常的、天然发生的 HIV-1 控制:对功能性治愈的深入了解。
Med. 2024 Sep 13;5(9):1071-1082. doi: 10.1016/j.medj.2024.06.008. Epub 2024 Jul 15.
8
Epistatic interaction between ERAP2 and HLA modulates HIV-1 adaptation and disease outcome in an Australian population.澳大利亚人群中 ERAP2 和 HLA 之间的上位性相互作用调节 HIV-1 的适应性和疾病结局。
PLoS Pathog. 2024 Jul 9;20(7):e1012359. doi: 10.1371/journal.ppat.1012359. eCollection 2024 Jul.
9
A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size.基于队列的宿主基因表达研究:与 HIV 储存库大小相关的肿瘤抑制因子和固有免疫/炎症途径。
PLoS Pathog. 2023 Nov 29;19(11):e1011114. doi: 10.1371/journal.ppat.1011114. eCollection 2023 Nov.
10
Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions.早期抗逆转录病毒治疗后进行治疗性疫苗接种可引发针对保守 HIV-1 区域的高功能 T 细胞反应。
Sci Rep. 2023 Oct 11;13(1):17155. doi: 10.1038/s41598-023-42888-3.

本文引用的文献

1
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.未经治疗却能控制HIV感染的人群中的基因和免疫异质性。
J Infect Dis. 2008 Feb 15;197(4):563-71. doi: 10.1086/526786.
2
Measuring HIV-1-specific T cell immunity: how valid are current assays?测量HIV-1特异性T细胞免疫:当前检测方法的有效性如何?
J Infect Dis. 2008 Feb 1;197(3):337-9. doi: 10.1086/525288.
3
Cross-clade detection of HIV-1-specific cytotoxic T lymphocytes does not reflect cross-clade antiviral activity.HIV-1特异性细胞毒性T淋巴细胞的跨亚型检测并不反映跨亚型抗病毒活性。
J Infect Dis. 2008 Feb 1;197(3):390-7. doi: 10.1086/525281.
4
Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.人类免疫缺陷病毒控制者:在无抗逆转录病毒治疗情况下持久控制病毒的机制
Immunity. 2007 Sep;27(3):406-16. doi: 10.1016/j.immuni.2007.08.010.
5
Pol-specific CD8+ T cells recognize simian immunodeficiency virus-infected cells prior to Nef-mediated major histocompatibility complex class I downregulation.在Nef介导的主要组织相容性复合体I类下调之前,Pol特异性CD8 + T细胞就能识别感染猿猴免疫缺陷病毒的细胞。
J Virol. 2007 Nov;81(21):11703-12. doi: 10.1128/JVI.00926-07. Epub 2007 Aug 15.
6
A whole-genome association study of major determinants for host control of HIV-1.一项关于宿主对HIV-1控制的主要决定因素的全基因组关联研究。
Science. 2007 Aug 17;317(5840):944-7. doi: 10.1126/science.1143767. Epub 2007 Jul 19.
7
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.HIV 控制者在体外表现出强大的 CD8 T 细胞抑制 HIV 感染的能力以及独特的细胞毒性 T 淋巴细胞激活表型。
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6776-81. doi: 10.1073/pnas.0611244104. Epub 2007 Apr 11.
8
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia.抗逆转录病毒疗法将血浆中的HIV-1 RNA抑制到由治疗前病毒血症预测的稳定水平。
PLoS Pathog. 2007 Apr;3(4):e46. doi: 10.1371/journal.ppat.0030046.
9
Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression.针对gag的CD8 + T淋巴细胞在艾滋病病毒整合和病毒蛋白表达之前就能识别被感染的细胞。
J Immunol. 2007 Mar 1;178(5):2746-54. doi: 10.4049/jimmunol.178.5.2746.
10
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load.CD8 + T细胞对不同HIV蛋白的反应与病毒载量存在不一致的关联。
Nat Med. 2007 Jan;13(1):46-53. doi: 10.1038/nm1520. Epub 2006 Dec 17.

人类白细胞抗原I类分子限制的T细胞应答可能有助于控制人类免疫缺陷病毒感染,但这种应答对于长期病毒控制并非总是必要的。

HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.

作者信息

Emu Brinda, Sinclair Elizabeth, Hatano Hiroyu, Ferre April, Shacklett Barbara, Martin Jeffrey N, McCune J M, Deeks Steven G

机构信息

Positive Health Program, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, California, USA.

出版信息

J Virol. 2008 Jun;82(11):5398-407. doi: 10.1128/JVI.02176-07. Epub 2008 Mar 19.

DOI:10.1128/JVI.02176-07
PMID:18353945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2395228/
Abstract

A rare subset of human immunodeficiency virus (HIV)-infected individuals maintains undetectable HIV RNA levels without therapy ("elite controllers"). To clarify the role of T-cell responses in mediating virus control, we compared HLA class I polymorphisms and HIV-specific T-cell responses among a large cohort of elite controllers (HIV-RNA < 75 copies/ml), "viremic" controllers (low-level viremia without therapy), "noncontrollers" (high-level viremia), and "antiretroviral therapy suppressed" individuals (undetectable HIV-RNA levels on antiretroviral therapy). The proportion of CD4(+) and CD8(+) T cells that produce gamma interferon (IFN-gamma) and interleukin-2 (IL-2) in response to Gag and Pol peptides was highest in the elite and viremic controllers (P < 0.0001). Forty percent of the elite controllers were HLA-B57 compared to twenty-three percent of viremic controllers and nine percent of noncontrollers (P < 0.001). Other HLA class I alleles more common in elite controllers included HLA-B13, HLA-B58, and HLA-B81 (P < 0.05 for each). Within elite and viremic controller groups, those with protective class I alleles had higher frequencies of Gag-specific CD8(+) T cells than those without these alleles (P = 0.01). Noncontrollers, with or without protective alleles, had low-level CD8(+) responses. Thus, certain HLA class I alleles are enriched in HIV controllers and are associated with strong Gag-specific CD8(+)IFN-gamma(+)IL-2(+) T cells. However, the absence of evidence of T cell-mediated control in many controllers suggests the presence of alternative mechanisms for viral control in these individuals. Defining mechanisms for virus control in "non-T-cell controllers" might lead to insights into preventing HIV transmission or preventing virus replication.

摘要

一小部分感染人类免疫缺陷病毒(HIV)的个体在未经治疗的情况下可维持检测不到的HIV RNA水平(“精英控制者”)。为了阐明T细胞反应在介导病毒控制中的作用,我们在一大群精英控制者(HIV-RNA<75拷贝/毫升)、“病毒血症控制者”(未经治疗的低水平病毒血症)、“非控制者”(高水平病毒血症)和“抗逆转录病毒治疗抑制”个体(抗逆转录病毒治疗下检测不到HIV-RNA水平)中比较了HLA I类多态性和HIV特异性T细胞反应。精英控制者和病毒血症控制者中,对Gag和Pol肽产生γ干扰素(IFN-γ)和白细胞介素-2(IL-2)的CD4(+)和CD8(+)T细胞比例最高(P<0.0001)。40%的精英控制者为HLA-B57,相比之下,病毒血症控制者为23%,非控制者为9%(P<0.001)。在精英控制者中更常见的其他HLA I类等位基因包括HLA-B13、HLA-B58和HLA-B81(每种P<0.05)。在精英控制者和病毒血症控制者组中,具有保护性I类等位基因的个体中Gag特异性CD8(+)T细胞频率高于没有这些等位基因的个体(P=0.01)。无论有无保护性等位基因,非控制者的CD8(+)反应水平都很低。因此,某些HLA I类等位基因在HIV控制者中富集,并与强大的Gag特异性CD8(+)IFN-γ(+)IL-2(+)T细胞相关。然而,许多控制者中缺乏T细胞介导控制的证据表明这些个体存在病毒控制的替代机制。确定“非T细胞控制者”中病毒控制的机制可能会为预防HIV传播或阻止病毒复制带来启示。